China's vitamin C API export prices to maintain uptrend in H2
Shanghai. September 10. INTERFAX-CHINA - Prices of China's vitamin C active pharmaceutical ingredient exports look set to continue growing in the second half of this year due to large international market demands, according to a report released by the China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) on Sept. 10.
CSRC gives nod to Salubris Pharma IPO
Shanghai. September 9. INTERFAX-CHINA - The China Securities Regulatory Commission approved the initial public offering application of Shenzhen Salubris Pharmaceutical Co. Ltd. on Sept. 8, according to the CSRC's Web site.
Hony Capital and Huahai Medical to take on e-health market
Penicillin G API exports from China to rise after September - analyst
Shanghai. September 9. INTERFAX-CHINA - Penicillin G active pharmaceutical ingredient exports from China are expected to rise between October and the end of this year due to an increase in global penicillin demand, a pharmaceutical analyst told Interfax on Sept. 8.
NDRC leaves $10 mln in drug funds idle for five years
Shanghai. September 9. INTERFAX-CHINA - The National Development and Reform Commission has left funds amounting to nearly $10 million idle over the past five years that were allocated towards building up the national drug reserve, according to an announcement by the National Audit Office on Sept. 5.
Hi-tech park success a walk in the park for SIP Bio & Nano
Xi'an Biken develops new life detection instrument
Half of Chinese pharma companies will capitalize on health reform - insiders
Lack of quantitative standards bars China's TCMs from entering international market
China receives high-quality pig imports
Chinese health authorities halt use of unapproved large medical device to treat tumors
Genetics and pharmaceutical generics a focus of revised Chinese Patent Law
China's API sector to see slower profit growth in Q3
New caps on China's hospital drug prices will mostly affect foreign companies - source
Pharma companies, institutes band to set up company for Guangdong drug development center
SFDA to support MoH in establishing essential drug system
Tianyao Pharma completes China's first androstenedione production plant
SFDA distributes drug approval responsibilities among divisions
Chinese pharma industry's January to July sales value up 30 pct year-on-year
Kangmei Pharma to expand business in northeastern China with new subsidiary
Chinese pharma companies start to look to global patents to boost value
Simcere Pharma close to finishing phase four clinical trials on anti-tumor drug
Finger on the pulse: Pfizer says China R & D operations key to global strategy
MoH restructure plan gets State Council nod, to be completed by year's end
Roche increases marketing efforts in China as lymph cancer incidence rises
Yangtze River Delta to boast largest CRO cluster in the world by 2015 - insider
MoST to invest in biological research projects over next three years